| 46.68 Real-Time Quote |  +0.75 / +1.63%Today’s Change | 17.25 Today|||52-Week Range 58.91 | +74.70% Year-to-Date |
| Biotech Stock Mailbag: Exact Sciences, Questcor, Biotech M&A, Celsion Jun 14 / TheStreet.com | Questcor Surges on Drug Acquisition - Analyst Blog Jun 12 / Zacks.com |
| What Is the bTrueb Intention Behind This Market-Moving Drug Acquisition? Jun 13 / MotleyFool.com | Here's What This $4 Billion Winning Hedge Fund Company Has Bought and Sold Jun 12 / MotleyFool.com |
| Questcor Pop: Acquisition Trumps Competition Jun 13 / MotleyFool.com | Why Questcor Pharmaceuticals Shares Exploded Higher Jun 11 / MotleyFool.com |
| Questcor Rises On Unusually High Volume (QCOR) Jun 12 / TheStreet.com | Questcor Buys Potential Rival Drug Jun 11 / MotleyFool.com |
| Previous close | 45.93 |
| Today’s open | 46.18 |
| Day’s range | 46.03 - 46.73 |
| Volume | 90,978 |
| Average volume (3 months) | 2,076,056 |
| Market cap | $2.7B |
| Dividend yield | 2.16% |
| Earnings growth (last year) | +159.50% |
| Earnings growth (this year) | +20.29% |
| Earnings growth (next 5 years) | +21.00% |
| Revenue growth (last year) | +133.44% |
| P/E ratio | 14.3 |
| Price/Sales | 3.16 |
| Price/Book | 16.62 |
| Today’s change | Today’s % change | |
|---|---|---|
| TAROTaro Pharmaceutical ... | -0.17 | -0.30% |
| INCYIncyte Corp | -0.13 | -0.61% |
| OPKOPKO Health Inc | 0.00 | 0.00% |
| UTHRUnited Therapeutics ... | -0.24 | -0.37% |
| Next reporting date | July 31, 2013 |
| EPS forecast (this quarter) | $0.98 |
| Annual revenue (last year) | $509.3M |
| Annual profit (last year) | $197.7M |
| Net profit margin | 38.81% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Don Matthew Bailey, MBA |
Chief Operating Officer Stephen Lahue Cartt, MBA |
Corporate headquarters Anaheim, California |
.
